ライフサイエンスコーパス: bacterial vaccine

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 potency to non-disease-inducing Ags using a bacterial vaccine.

2 emic or mucosal immunizations with viral and bacterial vaccines.

3 ing the use of MIP antigens for inclusion in bacterial vaccines.

4 kable improvement in the development of live bacterial vaccines.

5 , and it is now being used for several other bacterial vaccines.

6 ustained following vaccination with a killed bacterial vaccine adjuvanted with aluminum hydroxide and

7 hetic CpG-ODNs but not with the DNA of mixed bacterial vaccine and were shown to be phosphorothioate

8 es for the development of safe and effective bacterial vaccines and adjuvants.

9 crobial origin and to an orally administered bacterial vaccine, and plasma-derived IgG Abs to systemi

10 Generally, oral bacterial vaccines are acid labile and need to be admini

11 e present uncertainty of which live viral or bacterial vaccines can be given to immunodeficient patie

12 ation may be potentially applied to numerous bacterial vaccine candidates, and irradiated bacteria co

13 alysis of 6 civilian studies of mixed killed bacterial vaccines containing pneumococci identified sig

14 stematic review and reanalysis of studies of bacterial vaccine efficacy (VE) in preventing pneumonia

15 n turn, has led to a call for stockpiling of bacterial vaccines for pandemic preparedness.

16 size and nanometer size), we have designed a bacterial vaccine form that exhibits improved efficacy o

17 to multiple pneumococcal serotypes and that bacterial vaccines may play a role in preventing influen

18 e humoral immunity induced by many viral and bacterial vaccines mediates protection that is maintaine

19 Recombinant bacterial vaccines must be fully attenuated for animal o

20 ing mutations into candidate live attenuated bacterial vaccines offers a promising approach for the d

21 rt of the World Health Organization Invasive Bacterial-Vaccine Preventable Diseases (IB-VPD) surveill

22 ion of immature/T1 B cells by TLR ligands or bacterial vaccine rapidly induces T1 cells to divide, pr

23 a, as well as stockpiling of antibiotics and bacterial vaccines, should also be high priorities for p

24 has led to many advances in the discovery of bacterial vaccine targets.

25 rradiated Listeria monocytogenes as a killed bacterial vaccine, testing the hypothesis that irradiati

26 e elicited by oral delivery of a recombinant bacterial vaccine, tetanus toxin fragment C (TTFC) was e

27 ecular patterns found in attenuated viral or bacterial vaccines that function as Toll-like receptor (

28 A new target strategy in the development of bacterial vaccines, the induction of antibodies to micro

29 ended application as an endpoint measure for bacterial vaccine trials.

30 sistance marker-free DNA vaccines as well as bacterial vaccine vectors devoid of engineered antibioti

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。